140 related articles for article (PubMed ID: 35116226)
1. Urethral fistula and perineal collection during intravesical treatment for non-muscle invasive bladder cancer - A rare complication.
Ong K; Dyer J; Wilson M; Hayne D
Urol Case Rep; 2022 May; 42():102003. PubMed ID: 35116226
[TBL] [Abstract][Full Text] [Related]
2. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
Shepherd AR; Shepherd E; Brook NR
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
[TBL] [Abstract][Full Text] [Related]
3. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
4. Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer.
Rao MV; Ellimoottil C; Sondej T; Flanigan RC; Quek ML
Urol Oncol; 2013 Aug; 31(6):857-61. PubMed ID: 21868262
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin.
Li R; Sundi D; Zhang J; Kim Y; Sylvester RJ; Spiess PE; Poch MA; Sexton WJ; Black PC; McKiernan JM; Steinberg GD; Kamat AM; Gilbert SM
Eur Urol; 2020 Sep; 78(3):387-399. PubMed ID: 32143924
[TBL] [Abstract][Full Text] [Related]
6. Determining optimal maintenance schedules for adjuvant intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis.
Huang Z; Liu H; Wang Y; Zhang C; Xu T
Curr Med Res Opin; 2017 Aug; 33(8):1379-1387. PubMed ID: 28471272
[TBL] [Abstract][Full Text] [Related]
7. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.
Li R; Metcalfe MJ; Tabayoyong WB; Guo CC; Nogueras González GM; Navai N; Grossman HB; Dinney CP; Kamat AM
Eur Urol Oncol; 2019 May; 2(3):286-293. PubMed ID: 31200843
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
[TBL] [Abstract][Full Text] [Related]
9. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
[TBL] [Abstract][Full Text] [Related]
10. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
Gandhi NM; Morales A; Lamm DL
BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
[TBL] [Abstract][Full Text] [Related]
11. Bladder Contracture - A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy.
Garcia C; Jina H; Bergersen P; Chalasani V
Urol Case Rep; 2016 Jan; 4():22-4. PubMed ID: 26793570
[TBL] [Abstract][Full Text] [Related]
12. Systemic BCG-osis following intravesical BCG instillation for bladder carcinoma.
Liaw F; Tan YY; Hendry D
Clin Case Rep; 2017 Oct; 5(10):1569-1572. PubMed ID: 29026546
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré Syndrome following intravesical Bacillus Calmette-Guérin therapy for bladder cancer: a rare and intriguing case report.
Khor V; Fahmy O; Lee CKS; Khairul-Asri MG
Cent European J Urol; 2023; 76(4):311-314. PubMed ID: 38230320
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculous prostatic abscess following intravesical bacillus Calmette-Guerin immunotherapy: a case report].
Ye HY; Xu QQ; Huang XB; Ma K; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):1039-41. PubMed ID: 26679674
[TBL] [Abstract][Full Text] [Related]
15. Tuberculous Prostatic Abscess with Prostatorectal Fistula after Intravesical Bacillus Calmette-Guérin Immunotherapy.
Eom JH; Yoon JH; Lee SW; Kim HS; Park TY; Bang CS; Baik GH; Kim DJ
Clin Endosc; 2016 Sep; 49(5):488-491. PubMed ID: 26978160
[TBL] [Abstract][Full Text] [Related]
16. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Zhao H; Chan VW; Castellani D; Chan EO; Ong WLK; Peng Q; Moschini M; Krajewski W; Pradere B; Ng CF; Enikeev D; Vasdev N; Ekin G; Sousa A; Leon J; Guerrero-Ramos F; Tan WS; Kelly J; Shariat SF; Witjes JA; Teoh JY
Front Surg; 2021; 8():775527. PubMed ID: 34888347
[No Abstract] [Full Text] [Related]
17. Systemic Bacillus Calmette-Guérin (BCG) Infection With Renal Involvement: A Rare Complication of BCG Immunotherapy.
Afonso R; Fontes J; Pinto P; Romano M; Esteves A
Cureus; 2022 Dec; 14(12):e33134. PubMed ID: 36726926
[TBL] [Abstract][Full Text] [Related]
18. Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy.
Aslan G; Sevinc C; Tuna B; Ozkal S; Yorukoglu K
Indian J Urol; 2013 Jan; 29(1):70-2. PubMed ID: 23671372
[TBL] [Abstract][Full Text] [Related]
19. The use of intravesical BCG in urothelial carcinoma of the bladder.
Alhunaidi O; Zlotta AR
Ecancermedicalscience; 2019; 13():905. PubMed ID: 30915163
[TBL] [Abstract][Full Text] [Related]
20. [THE EFFECT OF LOW-DOSE INTRAVESICAL BACILLUS CALMETTE-GUÉRIN (BCG) INFUSION THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER].
Shiozaki M; Oike H; Haba T; Yamamoto T; Oguchi T; Iijima K; Kato H; Nishizawa S; Okaneya T
Nihon Hinyokika Gakkai Zasshi; 2020; 111(3):82-88. PubMed ID: 34305093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
